162 related articles for article (PubMed ID: 30451552)
1. Prediction of early mortality following stereotactic body radiotherapy for peripheral early-stage lung cancer.
Baker S; Sharma A; Peric R; Heemsbergen WD; Nuyttens JJ
Acta Oncol; 2019 Feb; 58(2):237-242. PubMed ID: 30451552
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
Firat S; Bousamra M; Gore E; Byhardt RW
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1047-57. PubMed ID: 11958901
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
Eriguchi T; Takeda A; Sanuki N; Tsurugai Y; Aoki Y; Oku Y; Hara Y; Akiba T; Shigematsu N
Lung Cancer; 2017 Jul; 109():62-67. PubMed ID: 28577952
[TBL] [Abstract][Full Text] [Related]
4. Response criteria in solid tumors (PERCIST/RECIST) and SUV
Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
[TBL] [Abstract][Full Text] [Related]
5. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?
Klement RJ; Belderbos J; Grills I; Werner-Wasik M; Hope A; Giuliani M; Ye H; Sonke JJ; Peulen H; Guckenberger M
J Thorac Oncol; 2016 Jul; 11(7):1132-9. PubMed ID: 27060654
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations.
Agarwal JP; Pilar A; Mummudi N; Gupta M; Laskar SG; Pathak RS; Tibdewal AR; Kinhikar R; Ghadi Y; Tandon S; Purandare N; Prabhash K; Patil V
Indian J Cancer; 2020; 57(1):18-24. PubMed ID: 31929233
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
Firat S; Byhardt RW; Gore E
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):357-64. PubMed ID: 12243808
[TBL] [Abstract][Full Text] [Related]
10. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer.
Kopek N; Paludan M; Petersen J; Hansen AT; Grau C; Høyer M
Radiother Oncol; 2009 Dec; 93(3):402-7. PubMed ID: 19559492
[TBL] [Abstract][Full Text] [Related]
11. Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer.
Baker S; Bakunina K; Duijm M; Hoogeman MS; Cornelissen R; Antonisse I; Praag J; Heemsbergen WD; Nuyttens JJ
Radiat Oncol; 2020 Apr; 15(1):89. PubMed ID: 32321553
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
Cerra-Franco A; Liu S; Azar M; Shiue K; Freije S; Hinton J; Deig CR; Edwards D; Estabrook NC; Ellsworth SG; Huang K; Diab K; Langer MP; Zellars R; Kong FM; Wan J; Lautenschlaeger T
Clin Lung Cancer; 2019 May; 20(3):186-193.e3. PubMed ID: 30711394
[TBL] [Abstract][Full Text] [Related]
13. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
Mak RH; Hermann G; Lewis JH; Aerts HJ; Baldini EH; Chen AB; Colson YL; Hacker FH; Kozono D; Wee JO; Chen YH; Catalano PJ; Wong KK; Sher DJ
Clin Lung Cancer; 2015 Jan; 16(1):24-32. PubMed ID: 25450872
[TBL] [Abstract][Full Text] [Related]
14. Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT.
Hörner-Rieber J; Bernhardt D; Blanck O; Duma M; Eich HT; Gerum S; Gkika E; Hass P; Henkenberens C; Herold HU; Hildebrandt G; Imhoff D; Kahl H; Janssen S; Jurianz K; Krempien R; Lautenschläger SF; Lohaus F; Mueller AC; Petersen C; Sackerer I; Scafa D; Schrade E; Uhlmann L; Wittig A; Guckenberger M
Clin Lung Cancer; 2019 Nov; 20(6):e667-e677. PubMed ID: 31327644
[TBL] [Abstract][Full Text] [Related]
15. Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience.
Hasan S; Colonias A; Mickus T; VanDeusen M; Wegner RE
Thorac Cancer; 2018 Jun; 9(6):699-706. PubMed ID: 29697204
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
17. Survival after stereotactic radiotherapy in patients with early-stage non-small cell lung cancer.
Hansen O; Kristiansen C; Nielsen M; Schytte T; Starup Jeppesen S
Acta Oncol; 2019 Oct; 58(10):1399-1403. PubMed ID: 31271094
[No Abstract] [Full Text] [Related]
18. Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy.
Shi S; Ye L; Zhao Q; Hu Y; Huang Y; Chen G; Zeng Z; He J
Jpn J Clin Oncol; 2019 Apr; 49(4):367-372. PubMed ID: 30715411
[TBL] [Abstract][Full Text] [Related]
19. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
